- Home
- TELO vs XCUR Comparison
TELO vs XCUR Comparison
Compare TELO & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- XCUR
- Stock Information
- Founded
- TELO 2021
- XCUR 2011
- Country
- TELO United States
- XCUR United States
- Employees
- TELO N/A
- XCUR N/A
- Industry
- TELO
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- TELO
- XCUR Health Care
- Exchange
- TELO NYSE
- XCUR Nasdaq
- Market Cap
- TELO 52.4M
- XCUR 46.0M
- IPO Year
- TELO 2024
- XCUR N/A
- Fundamental
- Price
- TELO $2.19
- XCUR $7.85
- Analyst Decision
- TELO
- XCUR
- Analyst Count
- TELO 0
- XCUR 0
- Target Price
- TELO N/A
- XCUR N/A
- AVG Volume (30 Days)
- TELO 9.2M
- XCUR 283.6K
- Earning Date
- TELO 08-12-2025
- XCUR 08-12-2025
- Dividend Yield
- TELO N/A
- XCUR N/A
- EPS Growth
- TELO N/A
- XCUR N/A
- EPS
- TELO N/A
- XCUR N/A
- Revenue
- TELO N/A
- XCUR N/A
- Revenue This Year
- TELO N/A
- XCUR N/A
- Revenue Next Year
- TELO N/A
- XCUR N/A
- P/E Ratio
- TELO N/A
- XCUR N/A
- Revenue Growth
- TELO N/A
- XCUR N/A
- 52 Week Low
- TELO $1.12
- XCUR $1.44
- 52 Week High
- TELO $8.40
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- TELO 64.07
- XCUR 50.95
- Support Level
- TELO $2.00
- XCUR $7.55
- Resistance Level
- TELO $2.44
- XCUR $9.50
- Average True Range (ATR)
- TELO 0.19
- XCUR 0.92
- MACD
- TELO 0.15
- XCUR 0.24
- Stochastic Oscillator
- TELO 54.04
- XCUR 50.73
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.